Oncology

Oncology

Surgery & Therapy

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
Home Gateways Oncology
21-40 of 63 ARTICLES
Previous Next
 in 
https://doi.org/10.12688/f1000research.73076.3
Research Article metrics
Revised
New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin
[version 3; peer review: 3 not approved]
Aya Essawy, Mai Mehrez, Sara M. Shaheen, Hassan El Garem, Nagwa A. Sabri
Peer Reviewers Asmaa Gomaa; Chia-Yen Dai; William L Irving
LATEST VERSION PUBLISHED 03 Jul 2024
https://doi.org/10.12688/f1000research.127691.2
Research Article metrics
Revised
Breast cancer related physical, psychological, social and spiritual domains of quality of life among women in Bahrain
[version 2; peer review: 1 approved, 2 not approved]
Gayathripriya Narayanan, Muyssar Sabri Awadallah, Rajeswari Krishnasamy
Peer Reviewers Salwa Hagag Abdelaziz; Chung-Ying Lin; Tharin Phenwan
LATEST VERSION PUBLISHED 28 May 2024
https://doi.org/10.12688/f1000research.132627.3
Research Article metrics
Revised
Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma
[version 3; peer review: 1 approved, 2 approved with reservations, 1 not approved]
Matt Sherwood, Yilu Zhou, Yi Sui, Yihua Wang, Paul Skipp, Carolini Kaid, Juliet Gray, Keith Okamoto, Rob M. Ewing
Peer Reviewers Griffith D Parks; Estanislao Nistal-Villan and Vicent Tur-Planells; Thomas C. N. Leung; Monica Martinez Pacheco
  • Funders
  • Rosetrees Trust
  • Neuroblastoma UK
  • Medical Research Council
  • Children's Cancer and Leukaemia Group
  • Wessex Medical Research
LATEST VERSION PUBLISHED 21 May 2024
https://doi.org/10.12688/f1000research.145493.2
Review metrics
Revised
Hepatocellular carcinoma: Advances in systemic therapies
[version 2; peer review: 3 approved]
Trevor Kwan-Hung Wu, Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, Wai-Kay Seto, Man-Fung Yuen
Peer Reviewers Won-Mook Choi; Shang-Chin Huang; Leonardo Stella
LATEST VERSION PUBLISHED 07 May 2024
https://doi.org/10.12688/f1000research.146356.1
Research Article metrics
Impact of CYP3A4 rs2242480 polymorphisms on Imatinib HPLC determined trough concentration and response in Chronic Myeloid Leukaemia in Pakistani patients
[version 1; peer review: 1 approved with reservations, 1 not approved]
Dr. Asma Khan, Dr. Zunera Hakim, Dr. Akbar Waheed, Dr. Naila Abrar
Peer Reviewers Aijun Zhang; Nicholas Cross
PUBLISHED 22 Apr 2024
https://doi.org/10.12688/f1000research.135809.2
Method Article metrics
Revised
Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients
[version 2; peer review: 2 approved]
Hannah Gagg, Sophie T. Williams, Samantha Conroy, Katie N. Myers, Connor McGarrity-Cottrell, Callum Jones, Thomas Helleday, Juha Rantala, Ola Rominiyi, Sarah J. Danson, Spencer J. Collis, Greg Wells
Peer Reviewers Natividad Gomez-Roman; Anke Brüning-Richardson
  • Funders
  • Urology Foundation
  • Brain Tumour Charity
  • Weston Park Cancer Charity
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
LATEST VERSION PUBLISHED 11 Mar 2024
https://doi.org/10.12688/f1000research.142468.1
Research Article metrics
Assessing the impact of frequent mammography after breast cancer treatment from a single-institution retrospective analysis
[version 1; peer review: 1 approved with reservations]
Kellie Spector, Alexis LeVee, Scott Karlan, Farin Amersi, Arjan Gower, Heather McArthur
Peer Reviewers Louiza S Velentzis
PUBLISHED 14 Dec 2023
https://doi.org/10.12688/f1000research.135154.3
Case Report metrics
Revised
Case Report: A Pathological Odyssey in Primary Cutaneous Apocrine Carcinoma
[version 3; peer review: 2 approved, 1 approved with reservations]
Dr. Suhit Naseri, Samarth Shukla, Dr. Sourya Acharya, Sunita Vagha
Peer Reviewers Rehan Zahid; Nour Kibbi; Dr. Ashwinkumar Barsagade
LATEST VERSION PUBLISHED 08 Nov 2023
https://doi.org/10.12688/f1000research.134816.1
Research Article metrics
Patient’s attitudes and perceptions around attending oncology consultations following surgery for colorectal cancer: A qualitative study
[version 1; peer review: 3 approved]
Yoshan Moodley, Shona Bhadree, Laura Stopforth, Shakeel Kader, Steven Wexner, Jacqueline van Wyk, Alfred Neugut, Ravi Kiran
Peer Reviewers Shanaz Ghuman; Haniee Chung; Rajesh Balkrishnan
  • Funder
  • National Institutes of Health
PUBLISHED 19 Jun 2023
https://doi.org/10.12688/f1000research.122741.2
Study Protocol metrics
Revised
Protocol for a randomized study of the efficacy of ibandronic acid plus eldecalcitol in patients with gastric cancer after gastrectomy: A comparative study of different routes of administration of ibandronic acid
[version 2; peer review: 2 approved]
Hisaki Aiba, Nobuyuki Suzuki, Hiroyuki Sagawa, Hiroya Hashimoto, Hiroaki Kimura, Jumpei Inoue, Takuya Usami, Yuta Goto, Yuichiro Mizuno, Tomotaka Okubo, Sunao Ito, Shuji Takiguchi, Hideki Murakami
Peer Reviewers Carlen Reyes; Friederike Thomasius
LATEST VERSION PUBLISHED 05 May 2023
https://doi.org/10.12688/f1000research.131710.1
Review metrics PEER REVIEW DISCONTINUED
Data presentation of results from randomized cancer clinical trials. The case for trials in advanced cervical cancer. A critical appraisal.
[version 1; peer review: peer review discontinued]
Alfonso Duenas Gonzalez, Jaime Coronel, Paula Cabrera-Galeana, Myrna Candelaria, Claudia Cano-Blanco
Peer Reviewers Invited
  • Funder
  • The author declared that no grants were involved in supporting this work.
PUBLISHED 13 Mar 2023
https://doi.org/10.12688/f1000research.130888.1
Research Article metrics AWAITING PEER REVIEW
Network biology of lapatinib resistance in different types of HER2-positive breast cancers informs the prioritization of the combination anticancer treatments as anti-resistance interventions
[version 1; peer review: awaiting peer review]
Bayan Alkhawaja, Anas Khaleel, Wael Abu Dayyih, Mohammed F. Hamad, Rima Hajjo, Mohammad Hailat
Peer Reviewers Invited
PUBLISHED 09 Mar 2023
https://doi.org/10.12688/f1000research.130716.1
Clinical Practice Article metrics
Oncoplastic breast volume replacement with the use of lateral intercostal artery perforator flap
[version 1; peer review: 2 approved with reservations]
Sinta Chaira Maulanisa, I Gusti Ngurah Gunawan Wibisana
Peer Reviewers Dedy Hermansyah; Kanchana Wijesinghe
PUBLISHED 01 Mar 2023
https://doi.org/10.12688/f1000research.127528.1
Research Article metrics AWAITING PEER REVIEW
Impact of serum leptin and adiponectin levels on breast cancer in postmenopausal Iraqi women: an observational Study
[version 1; peer review: awaiting peer review]
Mohammed A. Abd, Shaymaa A. Abbas, Laith G. Shareef
Peer Reviewers Invited
PUBLISHED 23 Dec 2022
https://doi.org/10.12688/f1000research.108628.2
Review metrics
Revised
p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
[version 2; peer review: 2 approved]
Freda Halim, Yohana Azhar, Suwarman Suwarman, Bethy Hernowo
Peer Reviewers Didik Setyo Heriyanto; Norbert Nass
LATEST VERSION PUBLISHED 30 Nov 2022
https://doi.org/10.12688/f1000research.126754.1
Research Article metrics
Tumour cell suppression by spiroleucettadine through dual regulation of cell cycle and apoptosis
[version 1; peer review: 1 approved]
Ben Watts, Maddie Berry, Abigail Bland, Michael Badart, Bill Hawkins, John Ashton
Peer Reviewers Brad Sutherland
  • Funder
  • University of Otago
PUBLISHED 16 Nov 2022
https://doi.org/10.12688/f1000research.126462.1
Research Article metrics
PD-L1 expression as predictor of immunotherapy eligibility in penile squamous cell carcinoma patients
[version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]
Muhammad Haritsyah Warli, Fauriski Febrian Prapiska, Ginanda Putra Siregar, Bungaran Sihombing, Syah Mirsya Warli
Peer Reviewers Thomas S. Gerald; Jan Hrudka; Dr.Sourav Kumar Mishra
PUBLISHED 09 Nov 2022
https://doi.org/10.12688/f1000research.126905.1
Case Report metrics
Case Report: A pericardial effusion secondary to cardiac desmoplastic small round cell tumor
[version 1; peer review: 2 approved with reservations]
Nehemias Guevara, Jane Atallah, Mailing Flores Chang, Steven Epstein, Rocco Lafaro, Ilmana Fulger
Peer Reviewers Fernand Bteich; Madelyn Espinosa-Cotton
PUBLISHED 28 Oct 2022
https://doi.org/10.12688/f1000research.125335.1
Case Report metrics
Case Report: Localized Ewing’s sarcoma of the scapula in an adult
[version 1; peer review: 1 approved with reservations]
Rafik Elafram, Majdi Ben Romdhane, Nayssem Khassairi, Sarrah Ben Rjeb, Saiffallah Toumi, Majdi Sghaier
Peer Reviewers Iyad Sultan
PUBLISHED 10 Oct 2022
https://doi.org/10.12688/f1000research.125428.1
Research Article metrics AWAITING PEER REVIEW
Factors predicting complications, neurologic deterioration and mortality for patients with meningioma surgery: An observational study
[version 1; peer review: awaiting peer review]
Aji Setia Utama, Joni Wahyuhadi, Muhammad Arifin, Asra Al Fauzi, Pudji Lestari, Kurnia Kusumastuti, Makhyan Jibril Al-Farabi, Yusuf Mannagalli
Peer Reviewers Invited
PUBLISHED 27 Sep 2022
21-40 of 63 ARTICLES
Previous Next
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.
Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.